U.S. Entertainment Stock News

How Exelon’s Recent Performance Might Look to Long Term Investors Exelon (EXC) has drawn fresh attention after a solid run, with the stock showing gains over the month, past 3 months, year to date, and the past year, alongside multi year total returns. For investors, the backdrop includes annual revenue of US$24.258b and net income of US$2.768b, with both revenue and net income growth reported on an annual basis, and a current share price of US$48.20. See our latest analysis for Exelon. The...

Oceaneering International (NYSE:OII) is expanding further into robotics and digital solutions, building on its large Subsea Robotics footprint and automation offerings. The company recently secured record-setting government work within its Aerospace & Defense Technologies segment, described as its largest contract win in that area to date. Management is also targeting bolt on M&A focused on technology capabilities, with an eye on offshore renewables and digital automation...

Charles Schwab filed a suspicious activity report with U.S. authorities related to multimillion dollar transfers linked to Jeffrey Epstein. The firm reported the wire activity and subsequently ended its business relationship connected to those transactions. The disclosures raise questions for investors about Schwab's compliance processes, risk controls, and approach to reputational exposure. For investors watching Charles Schwab, ticker NYSE:SCHW, this compliance story sits alongside a...

Kinsale Capital Group (KNSL) is back in focus after reporting its fourth quarter and full year 2025 results, alongside a new US$250 million share repurchase plan and continued dividends. See our latest analysis for Kinsale Capital Group. The recent earnings beat, new US$250 million buyback authorization and ongoing dividends come against a softer share price backdrop, with a 30 day share price return of an 8.36% decline and a 1 year total shareholder return of a 12.61% decline, while the 5...

If you are wondering whether Visa is attractively priced or already fully valued, you are not alone. This article will walk through what the current share price might be implying. Visa recently closed at US$306.52, with returns of a 2.4% decline over 7 days, a 6.0% decline over 30 days, an 11.5% decline year to date, and an 11.7% decline over 1 year. The 3 year and 5 year returns sit at 42.3% and 46.8% respectively. Recent headlines around Visa have focused on its role in global payments,...

If you are wondering whether Booz Allen Hamilton Holding is attractively priced today, you are not alone. Many investors are asking whether the current share price reflects its long term potential or short term noise. The stock last closed at US$74.26, with returns of a 6.4% decline over 7 days, a 27.4% decline over 30 days, a 12.5% decline year to date, a 32.3% decline over 1 year, a 17.7% decline over 3 years and a 2.6% gain over 5 years, which has changed how some investors may view its...

If you are wondering whether Carpenter Technology's share price still reflects fair value after a strong run, you are not alone. The stock closed at US$385.04, with returns of 1.4% over 7 days, 14.7% over 30 days, 13.8% year to date and 93.0% over the past year, plus a very large gain over 3 and 5 years. Recent headlines around Carpenter Technology have focused on its role as a specialty materials supplier in aerospace and industrial markets, alongside broader interest in suppliers tied to...

Recent performance snapshot NIKE (NKE) shares closed at US$63.09, with recent returns showing a 3.5% decline over the past day, broadly flat performance over the past week, and negative moves over the month and past 3 months. See our latest analysis for NIKE. At around US$63, NIKE’s recent 1 day and 1 month share price declines sit against a much weaker 1 year total shareholder return of 19.6% and a 5 year total shareholder return of 50.9%. This suggests momentum has been fading and investors...

DuPont de Nemours (DD) has caught investor attention after a strong past 3 months, with the stock showing a 29.1% total return. Recent business metrics offer more context for that move. See our latest analysis for DuPont de Nemours. That recent 29.1% three month total return sits alongside a 13.5% one month share price gain and a 49.5% one year total shareholder return. This suggests momentum has been building around DuPont de Nemours at the current US$50.08 share price. If this kind of move...

GeneDx Holdings (WGS) closed out FY 2025 with Q4 revenue of US$121.0 million and a basic EPS loss of US$0.61, alongside net income excluding extraordinary items of a US$17.7 million loss. Over recent quarters the company has seen revenue move from US$95.6 million in Q4 2024 to US$121.0 million in Q4 2025, while quarterly basic EPS has ranged from a loss of US$0.31 in Q3 2024 to a gain of US$0.38 in Q2 2025 and back to a loss of US$0.61 in the latest period. This sets up a story in which...

The Pennant Group (NASDAQ: PNTG), a senior living and home health provider, recently reported earnings after market close, following a prior quarter in which it exceeded revenue expectations and issued full-year revenue guidance above analyst estimates. With analysts maintaining their forecasts and projecting very strong year-on-year revenue growth for the latest quarter, investor attention has focused on whether Pennant’s operating momentum and guidance can sustain this level of...

Why Phillips Edison (PECO) is Back on Investor Radars Phillips Edison (PECO) has quietly drawn fresh attention after recent gains over the month and past 3 months, prompting investors to reassess this grocery anchored shopping center owner and its current valuation. See our latest analysis for Phillips Edison. Phillips Edison’s recent momentum, with a 30 day share price return of 10.88% and year to date gain of 11%, sits alongside a 1 year total shareholder return of 14.39%, suggesting steady...

Invesco (IVZ) is back in focus after recent share price moves, with the stock down about 11% over the past month but up roughly 4% in the past 3 months. See our latest analysis for Invesco. The recent weakness, including a 4.76% 1 day share price decline and an 11.23% 30 day share price pullback to US$25.21, sits against a much stronger 48.94% 1 year total shareholder return. This suggests that momentum has cooled after a solid run. If this volatility has you looking beyond asset managers, it...

Kroger recently appointed Greg Foran as Chief Executive Officer and expanded its initiatives through EVgo fast-charging installations, Home Chef’s Giada De Laurentiis collaboration, and enhanced Verified Savings support for SNAP customers. Together, these moves highlight Kroger’s emphasis on leadership stability, convenience-focused partnerships, and value offerings aimed at deepening customer loyalty across its grocery ecosystem. We’ll now examine how Greg Foran’s appointment as CEO may...

Earlier in 2026, Seldon Capital disclosed a US$6.83 million sale of 183,242 ACM Research shares, markedly reducing its ownership position as the company tightened its 2025 revenue outlook and outlined expectations for continued growth in 2026. This combination of a major shareholder stepping back while ACM Research scales revenue toward the billion-dollar level and invests in new U.S. capacity highlights a tension between institutional positioning and management’s expansion plans. Next,...

If you are wondering whether Incyte at around US$100.85 is priced for its future or leaving some value on the table, this article walks through what the numbers are really saying about the stock. Over the past week Incyte declined 0.3%. Over 30 days it declined 1.1%. Over the last year it returned 36.3%, with 3-year and 5-year returns of 31.6% and 26.6% respectively. These figures can naturally raise questions about where it sits on the risk and reward spectrum today. Recent headlines around...

In February 2026, Quest Diagnostics reported higher fourth-quarter and full-year 2025 sales and earnings, issued 2026 guidance calling for US$11.70–US$11.82 billion in revenue and US$9.45–US$9.65 in diluted EPS, raised its quarterly dividend to US$0.86 per share, and disclosed continued share repurchases under its long-running buyback program. The company also signaled continued expansion by pursuing hospital outreach and independent lab acquisitions, while using its questhealth.com platform...

Flowers Foods, Inc. recently reported Q4 2025 results showing sales of US$1,232.86 million but a net loss of US$67.07 million, driven in part by a US$135.98 million impairment of intangible assets, while also issuing 2026 sales guidance of US$5.16 billion to US$5.27 billion, indicating a 1.8% to 0.2% change from the prior year. Despite weaker profitability and upcoming retirements of long-serving directors George E. Deese and Edward J. Casey, Jr., the board approved a 3.1% increase in the...

FuboTV stock after recent performance FuboTV (FUBO) has been under pressure recently, with the share price at US$1.18 and negative returns over the past week, month, past 3 months and year to date drawing fresh attention from investors. See our latest analysis for FuboTV. The recent 1 day share price return of a 4.84% decline adds to a 30 day share price return of a 52.42% decline and a year to date share price return of a 54.44% decline, which points to fading momentum as investors reassess...

Beam Therapeutics entered a long term, non dilutive financing agreement with Sixth Street to support the potential launch of its sickle cell gene therapy. The deal provides access to up to $500 million in capital tied to Beam’s commercial plans for this program. The agreement focuses on funding potential product launch and commercialization activities rather than issuing new equity. For investors watching NasdaqGS:BEAM, this financing move comes with the stock trading around $28.33 and a...

Leonardo DRS, Inc. has reported past fourth-quarter 2025 sales of US$1,060 million and net income of US$102 million, raised full-year 2025 results versus 2024, declared a US$0.09 per-share cash dividend, and issued 2026 sales guidance of US$3,850 million to US$3,950 million while also securing access to a very large US$151 billion SHIELD IDIQ contract ceiling. An interesting angle for investors is how the combination of higher earnings per share, a new cash dividend, and eligibility to...

Freeport-McMoRan: recent performance puts copper miner in focus Freeport-McMoRan (FCX) is drawing investor attention after recent share price moves, with the stock up 1.9% over the past day, 4.3% in the past week, and 8.5% over the past month. See our latest analysis for Freeport-McMoRan. Those recent gains build on a stronger trend, with a 90 day share price return of 59.61% and a 1 year total shareholder return of 79.09%, suggesting momentum has been building over both shorter and longer...

In recent weeks, Intuitive Surgical has drawn attention as analysts highlighted its continued leadership in robotic-assisted surgery, supported by the entrenched da Vinci platform, expanding Ion diagnostic offering, and ongoing innovation in AI-driven tools. The news underscores how Intuitive’s wide clinical moat and growing mix of recurring instrument, accessory, and digital revenues may help counter rising competition, tariffs, and regulatory challenges. Next, we’ll examine how this...

Macy’s recently saw a surge in bearish options activity and rising caution tied to insider selling and an upcoming earnings report expected on March 5, adding pressure to sentiment around the retailer’s outlook. This comes as Macy’s continues to refresh its assortment and elevate its brand portfolio, including adding more luxury labels under its current leadership team. Next, we’ll examine how this spike in bearish options positioning ahead of earnings could influence Macy’s longer-term...